Regina Cseuz

673 total citations
8 papers, 233 citations indexed

About

Regina Cseuz is a scholar working on Genetics, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Regina Cseuz has authored 8 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Rheumatology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Regina Cseuz's work include Chronic Lymphocytic Leukemia Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (2 papers). Regina Cseuz is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (2 papers). Regina Cseuz collaborates with scholars based in United States, Belgium and United Kingdom. Regina Cseuz's co-authors include Maria Greenwald, Frédéric Vanhoutte, Arthur Kavanaugh, Mykola Stanislavchuk, O. V. Reshetko, Pille Harrison, Chantal Tasset, Joel M. Kremer, Annegret Van der Aa and George Kunos and has published in prestigious journals such as Endocrinology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Regina Cseuz

8 papers receiving 227 citations

Peers

Regina Cseuz
Dick E. de Vries United States
Regina Cseuz
Citations per year, relative to Regina Cseuz Regina Cseuz (= 1×) peers Dick E. de Vries

Countries citing papers authored by Regina Cseuz

Since Specialization
Citations

This map shows the geographic impact of Regina Cseuz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regina Cseuz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regina Cseuz more than expected).

Fields of papers citing papers by Regina Cseuz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regina Cseuz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regina Cseuz. The network helps show where Regina Cseuz may publish in the future.

Co-authorship network of co-authors of Regina Cseuz

This figure shows the co-authorship network connecting the top 25 collaborators of Regina Cseuz. A scholar is included among the top collaborators of Regina Cseuz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regina Cseuz. Regina Cseuz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Westhovens, René, Kevin Winthrop, Arthur Kavanaugh, et al.. (2025). Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study. RMD Open. 11(1). e004857–e004857. 2 indexed citations
2.
Alten, Rieke, René Westhovens, Arthur Kavanaugh, et al.. (2017). THU0173 Long term safety and efficacy of filgotinib in a phase 2B open label extension study in patients with rheumatoid arthritis: results up to 144 weeks. Annals of the Rheumatic Diseases. 76. 267–267. 3 indexed citations
3.
Fautrel, Bruno, M. van de Laar, Bruce Kirkham, et al.. (2017). THU0081 Differences in patient-reported outcomes between baricitinib and comparators among patients with rheumatoid arthritis who achieved low disease activity or remission. Annals of the Rheumatic Diseases. 76. 230–230. 2 indexed citations
4.
Kavanaugh, Arthur, Joel M. Kremer, Regina Cseuz, et al.. (2016). Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2). Annals of the Rheumatic Diseases. 76(6). 1009–1019. 176 indexed citations
5.
Kavanaugh, Arthur, Regina Cseuz, O. V. Reshetko, et al.. (2016). THU0173 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective as Monotherapy in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study. Annals of the Rheumatic Diseases. 75. 247–247. 11 indexed citations
6.
Cseuz, Regina, István Barna, Tamás Bender, & Jürgen Vormann. (2009). Alkaline Mineral Supplementation Decreases Pain in Rheumatoid Arthritis Patients: A Pilot Study. 2(1). 100–105. 3 indexed citations
7.
Cseuz, Regina & G. S. Panayi. (1990). THE INHIBITION OF NK CELL FUNCTION BY AZATHIOPRINE DURING THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS. Lara D. Veeken. 29(5). 358–362. 10 indexed citations
8.
Cseuz, Regina, Thomas L. Wenger, George Kunos, & M Szentiványi. (1973). Changes of Adrenergic Reaction Pattern in Experimental Diabetes Mellitus. Endocrinology. 93(3). 752–755. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026